Safe Surf Rated Back To Home Page Family Friendly Site
About
Bradford
  HIV/AIDS
Articles
  Alternative
Therapies
  HIV/AIDS
Videos
  HIV/AIDS
Links
  HIV/AIDS
News

Introduction:
Positively Positive
- Living with HIV
  Out
About
HIV
  Resume/
Curriculum Vitae:
HIV / AIDS Involvements
  Biography   HIV/AIDS
News Archive
HIV/AIDS News Bradford McIntyre
   



Second-Generation Female Condom Is Now Available in the United States;
FC2 Female Condom Will Cost 30 Percent Less than Predecessor

Company Makes Announcement at a Meeting of Southeastern Reproductive Health Organizations; FHC Makes Special Commitment to Expand Access in U.S. Regions with Highest AIDS Case Rates

CHICAGO, IL-October 1, 2009 - The Female Health Company (FHC) (NASDAQ: FHCO) is announcing today that its second-generation FC2 Female CondomŽ, which received regulatory approval from the Food and Drug Administration in March as an HIV prevention method, is now available for purchase in the United States.

The company will make the announcement in Atlanta at a meeting of the Southeastern Urban Initiative for Reproductive Health, a coalition of reproductive health advocates from Southern states that is seeking increased federal funding for HIV prevention.

"America's HIV epidemic isn't going away. In fact, it's getting worse, and African American and Latino women are disproportionately impacted," said Dazon Dixon Diallo, Founder and President of SisterLove, a grassroots service organization based in Atlanta that supports HIV/AIDS prevention and reproductive health programs for women. "It's time to provide women in heavily impacted communities with expanded access to affordable women-controlled options, and the female condom becomes that choice. Women will use it if they have it."

"We're thrilled that FC2 is now available in the United States," said Mary Ann Leeper, FHC's senior strategic adviser, who will deliver a keynote address on the female condom and woman-initiated prevention at the Atlanta meeting. "We developed the female condom to provide women with access to HIV prevention that they can initiate. We know that women and men practice safer sex when they have access to more prevention methods, and we believe that access to the female condom can help millions of American women negotiate safer sex with their partners."

FC2 may be purchased from the Company's two public sector distributors: Total Access Group, Inc. www.totalaccessgroup.com and Global Protection Corporation, www.globalprotection.com/store. In addition, FHC has launched a website, www.fc2femalecondom.com, which includes tiered pricing information for ordering a minimum quantity of 25,000 units directly from the Company. Price per unit will decline based on the volume purchased. The maximum price to purchase FC2 from the Company's distributors is $0.82/unit regardless of quantity, approximately a 30% decrease from the unit price paid for FC1.

FC2 will be available in certain retail outlets, and FHC is seeking a partner with appropriate experience to promote FC2 directly to consumers in the U.S.

FHC Makes Commitment to Expanded Access and Education
Seven of the top 10 states ranked by the rate of AIDS cases are in the U.S. South, and FHC will announce today that it is initiating a program to work with a number of southern reproductive health service organizations to provide free allotments of FC2 Female Condoms as part of an introductory awareness and education program, including training for health care providers on how to integrate female condom education into reproductive health counseling.

Data from the Centers for Disease Control and Prevention (CDC) show that women represent a growing proportion of Americans living with HIV and AIDS. Over the past two decades, the percentage of women among all people living with HIV in the U.S. has increased from 8 percent to 27 percent. African American and Latino women are also disproportionately impacted by the epidemic. African American women account for 66 percent of new AIDS cases among American women, while Latino women are five times more likely than white women to be diagnosed with AIDS.

The AIDS case rate is significantly higher in the U.S. South than in other regions of the country, and the prevalence of HIV and AIDS cases in some southern communities is comparable to prevalence figures for West Africa.

More than 70 reproductive health and HIV/AIDS advocacy organizations in the U.S. have called on donors and implementing agencies to expand women's access to the female condom, which remains the only safe and effective method of woman-initiated HIV prevention currently available.

About The Female Health Company
The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. FC2 patents have been granted in Australia and South Africa and are pending in various other countries. FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world. The Female Health Company and its partners currently market the Female Condom under FCFemale CondomŽ, FC2 Female CondomŽ, RealityŽ, FemidomŽ, FemyŽ, and CareŽ.

"Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995:
The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

 

 

###

Media Contact:
Bryan Callahan
(202) 729-4255

Product/Programs:
Mary Ann Leeper
(434) 964-1488

Investor Contacts:
Donna Felch
(312) 595-9123

William R. Gargiulo, Jr.
(231) 526-1244

Source: Female Health Company
http://www.femalehealth.com/images/press_2009_09_30_FHCO_FC2_US.pdf


"Reproduced with permission - Female Health Company "

Female Health Company
www.femalehealth.com



...positive attitudes are not simply 'moods'

Site Map

Contact Bradford McIntyre.

Web Design by Trevor Uksik

Copyright © 2003-2017 Bradford McIntyre. All rights reserved.

DESIGNED TO CREATE HIV & AIDS AWARENESS